⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iiic hepatocellular carcinoma ajcc v7

Every month we try and update this database with for stage iiic hepatocellular carcinoma ajcc v7 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver DysfunctionNCT03217253
Ann Arbor Stage...
Ann Arbor Stage...
Metastatic Mali...
Stage III Hepat...
Stage IIIA Hepa...
Stage IIIB Hepa...
Stage IIIC Hepa...
Stage IV Hepato...
Stage IVA Hepat...
Stage IVB Hepat...
Unresectable So...
Laboratory Biom...
Pharmacological...
Tazemetostat
18 Years - National Cancer Institute (NCI)
Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver CancerNCT03439891
Stage III Hepat...
Stage IIIA Hepa...
Stage IIIB Hepa...
Stage IIIC Hepa...
Stage IV Hepato...
Stage IVA Hepat...
Stage IVB Hepat...
Nivolumab
Sorafenib
18 Years - University of California, San Francisco
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerNCT03257761
Extrahepatic Bi...
Gallbladder Ade...
Metastatic Panc...
Recurrent Chola...
Recurrent Gallb...
Recurrent Hepat...
Recurrent Intra...
Recurrent Pancr...
Stage III Gallb...
Stage III Hepat...
Stage III Intra...
Stage III Pancr...
Stage IIIA Gall...
Stage IIIA Hepa...
Stage IIIB Gall...
Stage IIIB Hepa...
Stage IIIC Hepa...
Stage IV Gallbl...
Stage IV Hepato...
Stage IV Pancre...
Stage IVA Gallb...
Stage IVA Hepat...
Stage IVA Intra...
Stage IVB Gallb...
Stage IVB Hepat...
Stage IVB Intra...
Unresectable Ga...
Unresectable Pa...
Durvalumab
Guadecitabine
18 Years - University of Southern California
Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver CancerNCT03439891
Stage III Hepat...
Stage IIIA Hepa...
Stage IIIB Hepa...
Stage IIIC Hepa...
Stage IV Hepato...
Stage IVA Hepat...
Stage IVB Hepat...
Nivolumab
Sorafenib
18 Years - University of California, San Francisco
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: